Capsovision Inc (CV) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Capsovision Inc   (NASDAQ: CV)
 

Capsovision Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Capsovision Inc inventory turnover ratio, the Capsovision Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.6 in the second quarter 2026, yet the ratio remained below the average, as CV's market remain challenging.Average inventory processing period, for the Capsovision Inc in Jun 30 2026 quarter, has decreased to 228 days, compare to 234 days, in the Mar 31 2026 quarter.

Within Healthcare sector 251 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1260 in the first quarter 2026, to 1686.

CV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Capsovision Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CV Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 54.64 % 32.79 % - - -
Y / Y Cost of Sales Growth 77.2 % -22.42 % -30.33 % -23.61 % -20.06 %
Inventory Turnover Ratio (TTM) 1.6 1.56 1.77 2.76 4.53
CV's Total Ranking # 1686 # 1260 # 0 # 0 # 0
Average inventory processing period 229 234 206 132 81
Seq. Inventory Growth 34.75 % 16.87 % -6.28 % 4.77 % 15.71 %
Seq. Cost of Sales Growth 77.2 % -49.08 % 96.4 % 0 % -22.42 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 252
Overall Market # 1686

Inventory Turnover Ratio Statistics
High Average Low
1.77 1.64 1.56
(Dec 31 2025)   (Mar 31 2026)



CV Company Profile >> Back to CV Efficiency Comparisons >> Compare CV Inventory Turnover Ratio to its Competitors

Financial Statements
Capsovision Inc 's Inventories $ 5 Millions Visit CV's Balance sheet
Capsovision Inc 's Cost of Revenues TTM $ 6 Millions Visit CV's Income Statement
What are CV's Sales? Visit CV's Sales by Segment

Other Inventory Turnover Ratios
Capsovision Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CV's Competitors
Inventory Turnover Ratio for CV's Suppliers
Inventory Turnover Ratio for CV's Customers

You may also want to know
CV's Sales Growth Rates CV's Pe Price to earnings ratio CV's Receivables Turnover Ratio CV's Stock Quote
CV's Net Income Growth Rates CV's Ps Price to Sales ratio CV's Sales per Employee CV's Asset Turnover Ratio
CV's Net Margin CV's Pb Price to Book ratio CV's Financial Strength Ratios CV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Becton Dickinson And Company  3.25 $ 11,161.000  Millions$ 3,429  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Iovance Biotherapeutics inc   3.09 $ 167.681  Millions$ 54  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Dexcom Inc   2.81 $ 1,864.400  Millions$ 663  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
Neogen Corporation  2.67 $ 461.474  Millions$ 173  Millions
Innoviva Inc   2.65 $ 102.975  Millions$ 39  Millions
Vycor Medical Inc   2.64 $ 0.301  Millions$ 0  Millions

Date modified: 2026-09-03T11:41:15+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.